U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Thaler KJ, Gartlehner G, Kien C, et al. Drug Class Review: Targeted Immune Modulators: Final Update 3 Report [Internet]. Portland (OR): Oregon Health & Science University; 2012 Mar.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Drug Class Review: Targeted Immune Modulators

Drug Class Review: Targeted Immune Modulators: Final Update 3 Report [Internet].

Show details

Appendix IEvidence profiles

Table 1. Evidence profile of comparisons of targeted immune modulators for the treatment of rheumatoid arthritis

Table 2. Evidence profile of comparisons of targeted immune modulators for the treatment of juvenile idiopathic arthritis

Table 3. Evidence profile of comparisons of targeted immune modulators for the treatment of ankylosing spondylitis in adults

Table 4. Evidence profile of comparisons of targeted immune modulators for the treatment of psoriatic arthritis in adults

Table 5. Evidence profile of comparisons of targeted immune modulators for the treatment of psoriatic arthritis in children

Table 6. Evidence profile of comparisons of targeted immune modulators for the treatment of Crohn’s disease in adults

Table 7. Evidence profile of comparisons of targeted immune modulators for the treatment of Crohn’s disease in children

Table 8. Evidence profile of comparisons of targeted immune modulators for the treatment of ulcerative colitis in adults

Table 9. Evidence profile of comparisons of targeted immune modulators for the treatment of ulcerative colitis in children

Table 10. Evidence profile of comparisons of targeted immune modulators for the treatment of plaque psoriasis (adults)

Table 11. Evidence profile of comparisons of targeted immune modulators for the treatment of plaque psoriasis (children)

Table 12. Evidence profile of comparisons of targeted immune modulators for adverse events in adults

Table 13. Evidence profile of comparisons of targeted immune modulators for adverse events in children

Table 14. Evidence profile of comparisons of targeted immune modulators for efficacy and harms in subgroups

Copyright © 2012, Oregon Health & Science University, Portland, Oregon.
Bookshelf ID: NBK110092
Contents

Views

Other titles in this collection

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...